Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-06-10
2008-06-10
Seamani, Margaret D. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S112000
Reexamination Certificate
active
07384954
ABSTRACT:
Compounds of formula I:wherein A and R1are as defined in the specification, processes for preparing them, pharmaceutical compositions containing them and their use in therapy, especially in the treatment or prophylaxis of psychotic and intellectual impairment disorders.
REFERENCES:
patent: 1219622 (2002-03-01), None
patent: 1219622 (2002-07-01), None
patent: 0215662 (2002-02-01), None
patent: 2004043960 (2004-05-01), None
Araki et al., Japanese Pharmacological Society, “Neuronal nicotinic receptor and psychiatric disorders: functional and behavioral effects of nicotine”, 2002, vol. 88, pp. 133-138.
U.S. Appl. No. 10/579,608, James Empfield, et al.
Empfield James R.
Phillips Eifion
Throner Scott
Astrazeneca AB
Mitchell Kenneth F.
Patané Michael A.
Rahmani Niloofar
Seamani Margaret D.
LandOfFree
4-substituted imidazoles does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-substituted imidazoles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-substituted imidazoles will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2815699